HomeIDRSF • OTCMKTS
add
Idorsia Ltd
Previous close
$1.00
Year range
$1.08 - $2.88
Market cap
158.46M CHF
Avg Volume
436.00
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (CHF) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 26.20M | -67.21% |
Operating expense | 63.99M | -6.32% |
Net income | -101.04M | -145.10% |
Net profit margin | -385.61 | -237.55% |
Earnings per share | — | — |
EBITDA | -83.92M | -83.27% |
Effective tax rate | -0.17% | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.15M | -61.24% |
Total assets | 512.84M | -21.48% |
Total liabilities | 1.64B | 10.43% |
Total equity | -1.13B | — |
Shares outstanding | 188.31M | — |
Price to book | -0.17 | — |
Return on assets | -37.84% | — |
Return on capital | -125.83% | — |
Cash Flow
Net change in cash
| (CHF) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -101.04M | -145.10% |
Cash from operations | -143.71M | -88.55% |
Cash from investing | -1.23M | -100.46% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -92.14M | -190.50% |
Free cash flow | -83.97M | -2,363.30% |
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Website
Employees
938
